FRANK HOUSTON: Open Payments
NPI 1598277691 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,287 in 165 payments from 18 companies in 2025. Trend: 2023 $8,499 · 2024 $6,883 · 2025 $7,287
Speaker / faculty: $4,500Food & beverage: $2,656Education: $131
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $5,112 |
| GENZYME CORPORATION | 13 | $323 |
| UCB, Inc. | 22 | $284 |
| Regeneron Healthcare Solutions, Inc. | 14 | $281 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $253 |
| Janssen Biotech, Inc. | 18 | $238 |
| LEO Pharma Inc. | 11 | $181 |
| Galderma Laboratories, L.P. | 19 | $169 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Arcutis Biotherapeutics, Inc. | 4 | $79 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, Bimzelx, TREMFYA, NEMLUVIO, ILUMYA, ADBRY.
Industry payments across NC — which companies pay providers there.
